Skip to main content
TipRanks
Go Ultimate75% OFF

Serina Therapeutics (SER) Financial Statements

261 Followers

Serina Therapeutics Financial Overview

Serina Therapeutics's market cap is currently $35.87M. The company's EPS TTM is $-1.75; its P/E ratio is -0.77; Serina Therapeutics is estimated to report earnings on March 30, 2027, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Mar 23Dec 21
Income Statement
Total Revenue$ 0.00$ 56.00K$ 3.15M$ 500.00K$ 3.46M
Gross Profit$ 0.00$ -138.00K$ 3.06M$ 500.00K$ -333.84K
Operating Income$ -24.02M$ -17.05M$ -3.13M$ -2.27M$ -1.63M
EBITDA$ -18.91M$ -10.49M$ 5.92M$ -2.60M$ -1.23M
Net Income$ -19.18M$ -11.14M$ 5.27M$ -2.68M$ -1.26M
Balance Sheet
Cash & Short-Term Investments$ 3.06M$ 3.67M$ 7.62M$ 645.00K$ 584.00K
Total Assets$ 6.95M$ 6.72M$ 8.97M$ 3.24M$ 3.15M
Total Debt$ 196.00K$ 268.00K$ 3.44M$ 18.12M$ 13.20M
Net Debt$ -2.86M$ -3.40M$ -4.17M$ 17.48M$ 12.62M
Total Liabilities$ 6.99M$ 6.22M$ 41.26M$ 20.56M$ 15.03M
Stockholders' Equity$ -37.00K$ 641.00K$ -32.29M$ -17.21M$ -11.83M
Cash Flow
Free Cash Flow$ -18.01M$ -17.16M$ -2.98M$ -2.09M$ -2.36M
Operating Cash Flow$ -17.95M$ -17.14M$ -2.48M$ -2.08M$ -2.25M
Investing Cash Flow$ -59.00K$ -22.00K$ -504.00K$ 980.94K$ 823.32K
Financing Cash Flow$ 17.41M$ 13.21M$ 10.07M$ 1.31M$ 1.08M

Currency in USD

Serina Therapeutics Earnings and Revenue History

-24M-12M012M-24000 %-12000 %0 %12000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Serina Therapeutics Liabilities to Assets

015M30M45M0 %250 %500 %750 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Serina Therapeutics Cash Flow

-20M-10M010M20M201720182019202020212022202320242025OperatingInvestingFinancing

Serina Therapeutics Forecast EPS vs Actual EPS

-0.7-0.6-0.5-0.4-0.3-0.2Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss